CLINICAL TRIAL: GH CARDIOVASCULAR RISK AND VISCERAL ADIPOSITY

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究调查了腹部脂肪含量高而生长激素（GH）含量低的女性。 这项研究的目的是调查生长激素替代疗法是否能减少这一人群的腹部脂肪。 由于腹部脂肪与心脏病风险增加有关，我们也在研究生长激素替代疗法是否能降低这一人群患心脏病的风险。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The study examines women who have both high levels of belly fat and low levels of growth hormone (GH). The purpose of the study is to investigate whether GH replacement therapy reduces belly fat in this population. Since belly fat is associated with an increased risk for heart disease, we are also studying whether GH replacement therapy reduces the risk of heart disease in this population.